C Diff Foundation News Today

In a total of 26 ibezapolstat-treated patients in Phases 2a and 2b, the Clinical Cure rate is 96% Meets protocol primary objective of assessing the primary...

TEMECULA, Calif., Jan. 27, 2023 (SEND2PRESS NEWSWIRE) — Neotrope®, a 40 year old marketing and entertainment company, announced today that it is now accepting applications from U.S. based 501(c)(3) charities

C Diff Foundation News Room and Media Kit 2022 - Pressroom and Press Releases from C Diff Foundation at Send2Press Newswire

ENewsChannels NEWS: -- C Diff Foundation announced today that the 9th Annual International C. diff. Conference and Health EXPO is honored to welcome over 40 international topic-experts dedicated in disciplines of healthcare, pharma, biotech, and academia. World-renowned presenters will deliver data and discuss critical information on a leading Healthcare-Associated Infection (HAI), Clostridioides difficile with global healthcare-associated issues on Nov. 4 - 5, 2021. :: News from eNewsChannels

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

Mar 16, 2021 TAMPA, Fla., March 16, 2021 (SEND2PRESS NEWSWIRE) –- C Diff Foundation, the leading Global Patient and Healthcare Organization Educating and Advocating for C. difficile (Clostridioides difficile, C. diff., CDAD, CDI) today announced that the organization has developed a free mobile application designed specifically for patients and families who have been impacted by a Clostridioides difficile infection. The free app, “C diff and You,” is available on the Apple Store and Googl...

ENewsChannels NEWS: -- C Diff Foundation, the leading Global Patient and Healthcare Organization Educating and Advocating for C. difficile (Clostridioides difficile, C. diff., CDAD, CDI) today announced that the organization has developed a free mobile application designed specifically for patients and families who have been impacted by a Clostridioides difficile infection. :: News from eNewsChannels

TAMPA, Fla., Jan 11, 2021 (SEND2PRESS NEWSWIRE) — While some patients diagnosed with Clostridioides difficile (C. diff., C. difficile, CDI) believe they have run into clinical trial roadblocks, due to the recent focus on the pandemic, the C Diff Foundation wants them to know they are not out of options. Safe and active clinical trials continue. Most Clinical trial sites have implemented protocols to disinfect, clean and maintain environmental safety for all visitors. Telehealth is also being...

C Diff Foundation Hosts Live-Online Symposium for Patients, Families and Caregivers 01/13/2021 | 06:00am EDT Send by mail : Message : Required fields TAMPA, Fla., Jan. 13, 2021 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation will host a free, live-online, and interactive symposium on Friday, Jan. 15 from 1 to 4 p.m. EST. Sponsored by Seres Therapeutics, the event is designed for patients who are being treated for a C. diff. infection in addition to those who are recovering or who have experience...

(TAMPA, Fla.) — NEWS: The C Diff Foundation will host a free, live-online, and interactive symposium on Friday, Jan. 15 from 1 to 4 p.m. EST. Sponsored by Seres Therapeutics, the event is designed for patients who are being treated for a C. diff. infection in addition to those who are recovering or who have experienced recurrences. The patients, family members and caregivers will all benefit from the information and up-to-date data presented. Presenters are among some of the top C diff. thou...